Share this:

BPS Announces New Board Members

Sheila Botts, Anita Siu and Laura Gordon Appointed

Hal Richards and Marianne Ivey Re-Appointed

 

Washington, DC – The Board of Pharmacy Specialties (BPS) is pleased to announce the appointment of new Board members for terms that will begin January 1, 2021.

 

Specialist Members

Hal E. Richards, PharmD, BCNSP
Dr. Richards was re-appointed to a second term and he serves as the Clinical Pharmacy Specialist in Critical Care Medicine at St. Joseph’s Candler Health System in Savannah, Georgia, where he has been Program Director for the PGY-2 residency in Critical Care Medicine since 2011. Dr. Richards also has a faculty appointment with The University of Georgia College of Pharmacy as Clinical Assistant Professor. He received his BS in Pharmacy degree and PharmD from The University of Georgia College of Pharmacy. He completed a PGY-2 residency in Nutrition Support/Critical Care from The University of Arizona. He was a member of the BPS Nutrition Support Pharmacy Specialty Council and was an initial member of the first BPS Critical Care Pharmacy Specialty Council and subsequently served as Chair.

 

Dr. Richards has served as a member of the BPS Board of Directors for the past three years and now enters his second term. Previously he had served as a member of the BPS Nominations Committee, Awards Committee and is the 2020 Chair of the BPS Finance Committee. He was a member of the BPS Nutrition Support Specialty Council and was a member of the first BPS Critical Care Specialty Council.

 

Sheila Botts, PharmD, FCCP, BCPP

Dr. Botts is the Regional Administrator of Clinical Pharmacy Services at Kaiser Permanente, Colorado, Clinical Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and Co-Director of the joint KP-CU Pharmacy Research Fellowship. While at Kaiser Permanente, she has supported efforts to implement regional measurement-based care programs for depression and population monitoring gaps, assessment of medication adherence programs, integration of clinical pharmacy technicians, and dissemination of pharmacy best practices. Prior to Kaiser Permanente, she served on the faculty of the University of Kentucky, College of Pharmacy where she developed and directed the ASHP accredited residency training program in Psychiatric Pharmacy at the Lexington VA Medical Center. She has served on the CPNP Board of Directors and President as well as the CPNP Foundation Board.

 

Dr. Botts completed her B.S. in Chemistry at Centre College in Danville, Kentucky and her PharmD at the University of Kentucky. She completed a specialty residency and 2-year clinical sciences research fellowship at the University of Texas Health Sciences Center at San Antonio and San Antonio State Hospital. She recently completed the Kaiser Permanente Strategic Leadership Program as well as the Academy for Excellence in Healthcare, Operational Excellence program, provided by The Ohio State University Fisher College of Business & Cardinal Health.

 

Dr. Botts is starting her first term on the BPS Board of Directors and replaces Jerry McKee, PharmD, MS, BCPP who has completed his second term of service. Previously she served two terms on the Psychiatric Pharmacy Specialty Council and two years as Chair of that Council.

 

Anita Siu, PharmD, BCPPS
Dr. Siu is a Clinical Professor and Director of Faculty Mentoring at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey and a Neonatal/Pediatric Pharmacotherapy Specialist at the K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center, a Member of the Hackensack Meridian Health. She received her Bachelor’s and Doctor of Pharmacy degree at Philadelphia College of Pharmacy and completed two years of pharmacy residency training in General Pediatrics and Neonatal/Pediatric Critical Care. Throughout the years, she has implemented therapeutic guidelines in neonates and pediatrics.

 

Dr. Siu is starting her first term on the BPS Board of Directors and replaces Peter G. Koval, PharmD, BCPS, CPP who has completed his second term of service. Previously she served on the Pediatric Pharmacy Specialty Council and was also the Chair of that Council.

 

Non-Specialist Member

Marianne F. Ivey, PharmD, MPH, FASHP, FFIP

Dr. Ivey’s experience includes serving as vice president, Pharmacy Services for the Health Alliance of Greater Cincinnati, an integrated health care system. She is professor emerita in the Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy at the University of Cincinnati. Her practice, research, and teaching expertise are in patient care delivery, automation, clinical outcomes, pharmacy resident training, leadership and pharmacy resource management in hospitals and integrated health systems. She chaired the University Hospital total quality improvement steering committee and served on the Health Alliance Six Sigma Steering Committee.

 

Dr. Ivey has served as ASHP president, chairman of the HOD, member of the Commission on Goals and the Commission on Credentialing and served as treasurer of ASHP and the ASHP Foundation. She received the Pharmacy Practice Award from the Federation of International Pharmaceutique (FIP) in September of 2011. She was President of the Hospital Pharmacy Section of FIP and serves on the Leadership Degree Advisory Board for the University of Cincinnati College of Pharmacy, the External Advisory Board of the University of Kentucky School of Pharmacy and the St. Louis College of Pharmacy President’s Advisory Council. Dr. Ivey has a B.S. from the University of Wisconsin. She received her Pharm.D. and M.P.H. from the University of Washington. She also completed the Wharton School’s hospital pharmacy executives program. Currently Dr. Ivey provides education and consulting in the areas of healthcare leadership and advocacy, safe medication management, postdoctoral training development and resource management and she now resides in Seattle, Washington.

 

Dr. Ivey has served as a member of the BPS Board of Directors for the past three years and now enters her second term.

 

Public Member
Laura Gordon, Chief Executive Officer I-ACT for Children
Ms. Gordon is a highly experienced executive leader with expertise in health policy and communications, organizational development and stakeholder engagement in the public and private healthcare sectors. She joined Institute for Advanced Clinical Trials for Children (I-ACT for Children) in 2018 as its first chief executive officer. The non-profit organization works to accelerate and enhance the quality of pediatric clinical trials so that children have timely access to medicines that have been proven safe and effective for them.

 

Ms. Gordon received her BA in journalism from Kent State University. Prior to joining I-ACT for Children, she was General Manager of the Health, Federal Government Services, Employee Engagement and Multicultural Engagement sectors for the Washington office of Edelman, a global communications agency. Ms. Gordon’s experience includes working with multiple healthcare stakeholders – including researchers, regulators, drug developers and patients and their families – to advance innovation in clinical trial design and execution.

 

Ms. Gordon is starting her first term on the BPS Board of Directors and replaces Rebecca S. Miller, MS, who has completed her second term of service.

 

BPS Chair, Karen Gunning commented; “BPS had strong interest in the call for Board members, with many well-qualified candidates for a limited number of positions. The Board members who have been appointed and re-appointed, just as their predecessors, bring a tremendous amount of knowledge and experience to BPS and they will help us advance our mission to improve patient care by promoting the recognition and value of specialized training, knowledge, and skills in pharmacy and specialty board certification of pharmacists.”

 

About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of interprofessional healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 46,000 active pharmacist certifications in fourteen specialties.

 

BPS Media Contact
Alexander Jean-Baptiste
Senior Manager, Social Media & Content Marketing 
ajeanbaptiste@aphanet.org
(202) 760-3836